Management of Patients with Bilateral Multifocal Colorectal Liver Metastases: ALPPS
Executive Summary
The management of bilateral multifocal colorectal liver metastases (CRLM) requires a sophisticated, multi-stage surgical approach to ensure complete tumor clearance while maintaining adequate liver function. This briefing document, based on clinical research from the Department of HPB Surgery at the Hospital Italiano de Buenos Aires, examines the transition from traditional resection to advanced techniques such as Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS).
Critical findings include:
Case Efficacy: Successful initial management of primary colorectal tumors and synchronous liver metastases can be achieved through combined procedures, such as hemicolectomy with en-bloc resection and liver biopsy.
Technological Integration: The use of Diffusion-Weighted Imaging (DWI) and Gadoxetic acid (Gd-EOB-DTPA) MRI has significantly increased diagnostic accuracy for staging liver metastases post-chemotherapy.
Surgical Innovation: ALPPS and two-stage hepatectomy (TSH) are established strategies for addressing extensive bilobar disease, though they carry risks of tumor progression during the interval between stages.
Outcome Predictors: Kinetic Growth Rate (KGR) and the ALPPS risk score are essential tools for predicting post-hepatectomy liver failure and avoiding futile interventions.
Clinical Case Analysis: Bilateral CRLM
The source context provides a specific case study of a 44-year-old female patient presenting with abdominal pain and obstipation.
Initial Presentation and Diagnosis
Imaging: CT scans revealed bilobar hypodense images in the liver and a 40 mm mass in the sigmoid colon causing complete obstruction. Chest and pelvis scans excluded extrahepatic disease.
Biomarkers: Carcinoembryonic antigen (CEA) was measured at 12 ng/ml, and carbohydrate antigen 19-9 (CA 19-9) was 31.7 U/ml.
Primary Surgical Intervention
The patient underwent a laparoscopic procedure that was converted to an open left hemicolectomy.
Scope of Resection: Because the sigmoid mass was adjacent to the parietal wall and left ovary, an en-bloc resection of the sigmoid colon and left ovary was performed.
Hepatic Assessment: A biopsy was taken from a superficial lesion in the right liver lobe.
Outcome: The postoperative course was uneventful, and the patient was discharged without major complications.
Diagnostic and Staging Modalities
Accurate staging is vital for determining the feasibility of liver resection. The research highlights several key imaging and assessment tools:
Surgical Strategies for Complex CRLM
The literature identifies several methodologies for managing extensive liver involvement, focusing on maximizing the Future Liver Remnant (FLR).
Two-Stage Hepatectomy (TSH) and ALPPS
Staged Resection: TSH is a common strategy for bilobar metastases, but "drop-out" (the failure to proceed to the second stage) is a significant concern.
ALPPS vs. TSH: Research compares outcomes between ALPPS and conventional TSH, noting that while ALPPS can induce rapid liver hypertrophy, it requires careful patient selection to avoid futility (using the ALPPS risk score).
R0 Resection: Achieving R0 resection (microscopically margin-negative) is identified as the key to long-term survival in staged procedures.
Parenchymal-Sparing Techniques
Benefits: Increased use of parenchymal-sparing surgery for bilateral metastases is associated with improved mortality without compromising oncologic outcomes.
Salvageability: This approach improves the "salvageability" of the patient in the event of recurrence.
Alternative and Supplemental Treatments
Radiofrequency Ablation (RFA): Studies compare hepatectomy to RFA, as well as the combination of 1-stage resection with RFA for bilobar metastases.
Pedicle Clamping: Analysis of 512 resections suggests that liver resection without pedicle clamping is feasible, though "salvage clamping" should remain an available policy.
Management of Liver Regeneration and Tumor Growth
A primary challenge in staged liver surgery is managing the growth of the liver remnant versus the potential growth of remaining tumors.
Portal Vein Embolization (PVE) vs. Ligation (PVL): Both methods are used to induce hypertrophy of the FLR before major hepatectomy.
The Growth Paradox: During the regeneration following portal vein occlusion, the growth rate of liver metastases can be more rapid than that of the liver parenchyma.
Kinetic Growth Rate (KGR): The growth rate of the liver remnant after PVE is a strong early predictor of post-hepatectomy liver failure.
Chemotherapy Interventions: Administering chemotherapy after PVE may protect against tumor growth during the hypertrophy phase before the final hepatectomy.
Risk Factors and Predictors of Failure
The document identifies several factors that predict unsuccessful outcomes in complex liver surgeries:
Tumor Progression: Progression during preoperative chemotherapy is a primary predictor of the failure to complete a two-stage hepatectomy.
Small FLR: Patients with a small future liver remnant are at higher risk of liver-related mortality unless rapid growth (monitored via KGR) is achieved.
Technical Failure: The "second hurdle" of TSH refers to the transition between the first and second resection, where many patients are lost due to disease progression or insufficient liver growth.
